CRP and cancer: Emerging evidence suggests that elevated baseline levels of CRP (Hilmy et al, 2005; Crumley et al, 2006a; Mitsuru et al, 2009; Johnson et al, 2010), abnormal GPS scores (Forrest et al, 2003; Crumley et al, 2006b; McMillan, 2009) and elevated NLR (Yamanaka et al, 2007; Halazun et al, 2008, 2009; Liu et al, 2010) or PLR (Smith et al, 2009) are not only negatively correlated with outcome after surgical resection but also in those with inoperable cancers.